• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 54-68 of 154 results

2007 Exhibit: Basson et al, Pharmaceutical Research, Vol 13

Document IPR2017-01648, No. 2007-27 Exhibit - Basson et al, Pharmaceutical Research, Vol 13 (P.T.A.B. May. 31, 2018)

cite Cite Document
Analyze

2009 Exhibit: Vidon, et al, Diabetes Research and Clinical Practice

Document IPR2017-01648, No. 2009-29 Exhibit - Vidon, et al, Diabetes Research and Clinical Practice (P.T.A.B. May. 31, 2018)

cite Cite Document
Analyze

2011 Exhibit: Deposition Transcript of Dr Fatemeh Akhlaghi

Document IPR2017-01648, No. 2011-31 Exhibit - Deposition Transcript of Dr Fatemeh Akhlaghi (P.T.A.B. May. 31, 2018)

cite Cite Document
Analyze

2003 Exhibit: Patent Owners Revised Notice of Deposition of Dr Fatemeh Akhlaghi

Document IPR2017-01648, No. 2003-23 Exhibit - Patent Owners Revised Notice of Deposition of Dr Fatemeh Akhlaghi (P.T.A.B. May. 31, 2018)

cite Cite Document
Analyze

2010 Exhibit: Declaration of Jennifer Dressman, PhD

Document IPR2017-01648, No. 2010-30 Exhibit - Declaration of Jennifer Dressman, PhD (P.T.A.B. May. 31, 2018)

cite Cite Document
Analyze

2006 Exhibit: Why Cmax is a Continuous Variable and Tmax is a Categorical Variab...

Document IPR2017-01648, No. 2006-26 Exhibit - Why Cmax is a Continuous Variable and Tmax is a Categorical Variable (P.T.A.B. May. 31, 2018)

cite Cite Document
Analyze

2008 Exhibit: Keraliya, et al, ISRN Pharmaceutics, Volume 2012

Document IPR2017-01648, No. 2008-28 Exhibit - Keraliya, et al, ISRN Pharmaceutics, Volume 2012 (P.T.A.B. May. 31, 2018)

cite Cite Document
Analyze

2005 Exhibit: FDA Guidance for Industry

Document IPR2017-01648, No. 2005-25 Exhibit - FDA Guidance for Industry (P.T.A.B. May. 31, 2018)

cite Cite Document
Analyze

2001 Exhibit: Letter from FDA approving NDA 21 574

Document IPR2017-01648, No. 2001 Exhibit - Letter from FDA approving NDA 21 574 (P.T.A.B. Oct. 11, 2017)

cite Cite Document
Analyze

2002 Exhibit: Approved Fortamet Label

Document IPR2017-01648, No. 2002 Exhibit - Approved Fortamet Label (P.T.A.B. Oct. 11, 2017)

cite Cite Document
Analyze

2001 Exhibit: Letter from FDA approving NDA 21 574

Document IPR2017-01648, No. 2001-21 Exhibit - Letter from FDA approving NDA 21 574 (P.T.A.B. Oct. 11, 2017)

cite Cite Document
Analyze

2002 Exhibit: Approved Fortamet Label

Document IPR2017-01648, No. 2002-22 Exhibit - Approved Fortamet Label (P.T.A.B. Oct. 11, 2017)

cite Cite Document
Analyze

1008 Exhibit: EX1008 Lupin Settlement

Document IPR2017-01648, No. 1008 Exhibit - EX1008 Lupin Settlement (P.T.A.B. Jun. 22, 2017)

cite Cite Document
Analyze

1009 Exhibit: EX1009 Mylan Settlement

Document IPR2017-01648, No. 1009 Exhibit - EX1009 Mylan Settlement (P.T.A.B. Jun. 22, 2017)

cite Cite Document
Analyze

1010 Exhibit: EX1010 Amendment

Document IPR2017-01648, No. 1010 Exhibit - EX1010 Amendment (P.T.A.B. Jun. 22, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 7 8 9 10 11 >>